The production of cultivated meat is based on known biotechnological processes that are identical to those used in other large-scale applications for cell culture technology. For this future market, GEMÜ offers complete valves, as well as measurement and control systems, from a single source.
Cultivated meat is a steadily growing market that represents an efficient and sustainable option for the future supply of meat. GEMÜ is entering this market and, thanks to their expertise, is becoming a competent partner for manufacturers of cultivated meat. As with other large-scale cell culture applications, such as antibody therapeutics, one or more bioreactors, which form the heart of the system, are used in the production. Auxiliary processes such as water treatment, filtration, heating and cooling systems are also required. As one of the world’s leading suppliers of valves and control systems for the pharmaceutical, biotechnology and foodstuff industries, GEMÜ can optimally support these processes with the appropriate components and the right expertise.
GEMÜ offers suitable solutions for the production of cultivated meat for both aseptic and non-aseptic areas.
Diaphragm valves (e.g. GEMÜ 650, GEMÜ 653, GEMÜ 687) and diaphragm globe valves (e.g. GEMÜ 657, GEMÜ F40) are mainly used for demanding, aseptic process steps such as inoculating the bioreactor or transferring the cells between the bioreactors. Drainage-optimized tank bottom valves that are based on the diaphragm valve principle guarantee aseptic cell harvesting with minimal product loss.
For the laboratory phase in the cultivated meat sector, customized and individually tailored single-use solutions guarantee the necessary process reliability and flexibility.
Auxiliary processes in which the media does not come into contact with surfaces that come into contact with the product are classed as non-aseptic applications and also play an important role at GEMÜ. Thanks to the extensive product range, globe valves (e.g. GEMÜ 550, GEMÜ 554), butterfly valves (e.g. GEMÜ R480, GEMÜ R490) or ball valves (e.g. GEMÜ B22, GEMÜ 24) can be used for this purpose.
"In combination with expandable automation components, our valves are technically very well positioned to support and drive forward the new cultivated meat market, from the laboratory phase through to commercial production," says Tibor Tot, Business Development Manager in the Business Unit Pharma, Food & Biotech.
The GEMÜ Group develops and manufactures valves, measurement and control systems for liquids, vapours and gases. GEMÜ is a global market leader when it comes to solutions for sterile applications.
The globally focused, independent family-owned enterprise was founded in 1964. In 2011, Gert Müller took over as Managing Partner together with his cousin Stephan Müller, becoming the second generation to run the company. The Group achieved a turnover of over €530 million in 2022 and currently employs over 2500 members of staff worldwide, over 1400 of whom are in Germany. They have six manufacturing locations: Germany, Switzerland and France, as well as China, Brazil and the USA. Their worldwide marketing is carried out across 27 subsidiaries, coordinated from Germany. Thanks to a large network of commercial partners, GEMÜ is now active in over 50 countries on all continents.
Please visit www.gemu-group.com for further information.
GEMÜ Gebr. Müller Apparatebau GmbH & Co. KG
Fritz-Müller-Straße 6-8
74653 Ingelfingen-Criesbach
Telefon: +49 (7940) 123-0
Telefax: +49 (7940) 123-192
http://www.gemu-group.com
Corporate Communication
Telefon: +49 (7940) 123-708
Fax: +49 (7940) 123-487
E-Mail: ivona.meissner@gemue.de